Pharmacology and clinical evaluation of vorinostat, a histone deacetylase inhibitorL(U) Jun-ling, FENG Yu-fei, FU De-xing187-189
Me-too drug, me-better drug and me-new drug in drug R&DZHENG Yu-guo, CHEN Dai-jie, ZHU Bao-quan190-192,198
Consideration in non-clinical safety evaluation of monoclonal antibody productsWANG Hai-xue, PENG Jian, ZHANG Ruo-ming, WANG Qing-li199-201,205
Standardization of tissue sampling and trimming from rats and mice in preclinical safety evaluation study张頔, LIN Zhi, 林志, 李珊珊, 李波202-205
Advances in the development of new generation of HIV-1 non-nucleoside reverse transcriptase inhibitorsZHU Jun-jie, CAO Jiang-ying, ZHAN Peng, ZHAO Cui-rong, LIU Xin-yong206-212
Current status of lactone/carboxylate salt equilibria of camptothecin as antitumor agentsGAO Ying, CHEN Jun, CAI Bao-chang217-221
Efficacy of compound enalapril and compound valsartan in patients with mild and moderate primary hypertensionWANG Li, HUANG Yan, WANG Fang, CHENG Xiao-ru, HE Qi-ming, PANG Hui-ming, BIAN Wen-yan, LI Yi-shi222-224,261